RGEN

#1089
Repligen Corp
125.3500 USD
+2.25%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
125.1650
126.5100
年范围
109.6600
175.5700
日变化
+2.25%
每月变动
+8.70%
6个月变化
-24.35%
年变化
-24.35%
前一天收盘价
122.5900
开盘价
125.5500
买价
卖价
最低价
125.1650
High
126.5100
交易量
41
展开完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 7.0611 B
  • Employee 2 000
  • Founded 1981
  • CEO Tony J. Hunt
  • Website www.repligen.com
  • Headquarter Delaware, United States
  • FIGI BBG000BS48J3
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
190.53
市销率
0.01

Repligen Corporation

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. The company is based in Waltham, Massachusetts, and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biopharmaceutical drug developers and contract development and manufacturing organizations worldwide.

新闻